Also found in: Medical.
MMRVMeasles, Mumps and Rubella Vaccine
References in periodicals archive ?
A total of 716 children aged 13-15 months were randomized (2:1:1) and received a single dose of each vaccine, which included coadministered MMRV plus MenC at the same visit (MMRV + MenC group), or MMRV followed 42 days later by MenC (MMRV group), or MenC followed 42 days later by MMRV (MenC group).
A combination MMRV vaccine is now available in Canada which facilitates the implementation of the two-dose varicella recommendation discussed previously.
The Study: In this retrospective study, researchers looked at data since January, 2014 from the Vaccine Adverse Event Reporting System for cases of babies under nine months of age receiving either the MMR or the MMRV vaccination.
Two children had cases of anaphylaxis after MMRV shots, but neither "was confirmed as acute anaphylaxis after chart review; both diagnoses were related to a history of allergic reactions.
2011-12 CDC Kindergarten Report, supra note 6, at 650-51 (reporting the percentage of children enrolled in kindergarten in each state who received a medical exemption); Gostin, supra note 11, at 380 (explaining that medical contraindications to vaccines can include a known allergy or a compromised immune system); Multiple VIS, supra note 51, at 2; MMRV VIS, supra note 50, at 1 (indicating children should not receive MMRV vaccines if they have a life-threatening allergy to vaccine components or a compromised immune system due to illness (e.
345) See generally Takacs, supra note 20 (giving an overview of how MMRV and REDD+ may address issues surrounding climate change, deforestation, and poverty).
A vaccine for varicella - the medical name for the illness - is available and could be added to the existing measles, mumps and rubella jab by using the recently licensed MMRV vaccination, the report says.
Mascola said children can get the first and recommended second shot with a new multiple vaccine that provides protection against measles, mumps, rubella and chickenpox -- the MMRV.
The effectiveness of this combined vaccine has been proven, but an open question is whether the side effects profile of the MMRV is the same as when the two shots are given separately.
The BioPlex 2200 MMRV IgG kit (measles; mumps; rubella; and the varicellazoster virus) for use on the company's BioPlex 2200 system provides simultaneous results for the four tests that are commonly ordered together from a single patient sample to determine a patient's susceptibility to MMRV.
MMRV was licensed in 2006 in the United States, and quickly recommended for routine use in children.